CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise · Stock Option | −12,200 | 30,300 | ||
| 2026-09-08 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise · Stock Option | −10,754 | 64,246 | ||
| 2026-09-04 | Budur Kumar CHIEF MEDICAL OFFICER | Sale | −5,500 | $41.98 | $231K | 18,615 |
| 2026-05-14 | Philip Ron M Director | Grant or award · Stock Option | +21,872 | 21,872 | ||
| 2026-05-14 | Sabater Juan A. Director | Grant or award · Stock Option | +21,872 | 21,872 | ||
| 2026-05-14 | Szyper Linda M Director | Grant or award · Stock Option | +21,872 | 21,872 | ||
| 2026-05-14 | Sender Gary Director | Grant or award · Stock Option | +21,872 | 21,872 | ||
| 2026-05-14 | Graf R. Mark Director | Grant or award · Stock Option | +21,872 | 21,872 | ||
| 2026-05-14 | Germano Geno J Director | Grant or award · Stock Option | +21,231 | 21,231 | ||
| 2026-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise | +18,750 | 32,997 | ||
| 2026-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Shares withheld for taxes | −8,882 | $31.83 | $283K | 24,115 |
| 2026-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −18,750 | 37,500 | ||
| 2026-04-14 | Reicin Glenn CHIEF FINANCIAL OFFICER | Grant or award · Stock Option | +164,309 | 164,309 | ||
| 2026-04-07 | Zaeske Adam H. CHIEF COMMERCIAL OFFICER | Option exercise | +7,500 | 7,500 | ||
| 2026-04-07 | Zaeske Adam H. CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −3,173 | $27.62 | $88K | 4,327 |
| 2026-04-07 | Zaeske Adam H. CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −7,500 | 7,500 | ||
| 2026-04-02 | Anastasiou Peter CHIEF OPERATING OFFICER | Grant or award · Stock Option | +212,241 | 212,241 | ||
| 2026-04-02 | Ignelzi Troy A. Director | Grant or award · Stock Option | +17,710 | 17,710 | ||
| 2026-01-26 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,746 | $37.15 | $139K | 24,521 |
| 2026-01-25 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise | +2,662 | 2,662 |
Page 2 of 14 · 268 trades